undamentalytics Newsletter

Alkermes plc. income statement

In fiscal 2025, Alkermes plc. reported revenue of $1.48bn, down 5.2% on the year before, operating income of $254m (a 17.2% margin) and net income of $242m, or $1.43 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Alkermes plc.: income statement, annual
Fiscal year2010Mar 20102011Mar 20112012Mar 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMSept 2026
Revenue1781873905966196287469031,0941,1711,0391,1741,1121,6631,5581,4761,754
Cost of revenue——————132155176180178197218253245196300
Gross profit——————6147499189918609768941,4101,3121,2791,453
Research and development9597142—272344387413425513395291273271245324430
Selling, general and administrative7783138—200312374422526599539550591690645702878
Operating income−43−46−8834−87−224−209−148−99−175−11298−641442125464
Interest expense6328—1313151215149111323231287
Income before tax−45−46−11413−14−224−214−143−127−197−9788−3142244429111
Income tax−5−1−1−7163−61512−014112−98725012
Net income−40−46−11421−30−227−208−158−139−197−111−48−158356367242−0
Diluted EPS−$0.42−$0.48−$0.99$0.14−$0.21−$1.52−$1.38−$1.03−$0.90−$1.25−$0.70−$0.29−$0.97$2.10$2.17$1.43−$0.00
Diluted shares (average)95m96m115m144m145m149m151m153m155m157m159m165m164m170m169m169m171m
EBITDA−18−37−40—11−139−114−495−95−3117672489449281145

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: ALKS vs HALOALKS vs INSMALKS vs MDGLALKS vs MRNA

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Alkermes plc.'s SEC filings (10-K and 10-Q), retrieved November 3, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Alkermes plc.